Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 19, 2024
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
Daniil Gataulin Reiterated (ADVM) at Strong Buy with Increased Target to $40 on, Mar 19th, 2024
Daniil Gataulin of Chardan Capital, Reiterated "Adverum Biotechnologies, Inc." (ADVM) at Strong Buy with Increased Target from $4 to $40 on, Mar 19th, 2024.
Daniil has made no other calls on ADVM in the last 4 months.
There is 1 other peer that has a rating on ADVM. Out of the 1 peers that are also analyzing ADVM, 0 agree with Daniil's Rating of Hold.
This is the rating of the analyst that currently disagrees with Daniil
- Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Increased Target to $40 on, Tuesday, February 6th, 2024
